1. Home/
  2. Compounds/
  3. selumetinib:piperlongumine (8:1 mol/mol)

selumetinib:piperlongumine (8:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2selumetinib:piperlongumine (8:1 mol/mol)
PharmacoGx selumetinib:piperlongumine (8:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to selumetinib:piperlongumine (8:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA ASCC1 CTRPv2 pan-cancer AAC -0.088 0.01
mRNA EMC6 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA TCP11L1 CTRPv2 pan-cancer AAC -0.09 0.01
mRNA MYBPC3 CTRPv2 pan-cancer AAC 0.088 0.01
mRNA IFNA8 CTRPv2 pan-cancer AAC 0.083 0.01
mRNA PICK1 CTRPv2 pan-cancer AAC 0.092 0.01
mRNA SLC47A1 CTRPv2 pan-cancer AAC -0.087 0.01
mRNA DENND5A CTRPv2 pan-cancer AAC -0.098 0.01
mRNA ANO3 CTRPv2 pan-cancer AAC 0.084 0.01
mRNA CHURC1-FNTB CTRPv2 pan-cancer AAC 0.097 0.01
Download CSV